Cargando…

Potential drug–drug interactions in Alzheimer patients with behavioral symptoms

The use of multi drug regimens among the elderly population has increased tremendously over the last decade although the benefits of medications are always accompanied by potential harm, even when prescribed at recommended doses. The elderly populations are particularly at an increased risk of adver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasqualetti, Giuseppe, Tognini, Sara, Calsolaro, Valeria, Polini, Antonio, Monzani, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573195/ https://www.ncbi.nlm.nih.gov/pubmed/26392756 http://dx.doi.org/10.2147/CIA.S87466

Ejemplares similares

Cardiovascular Risk and Quality of Life in Elderly People with Mild Thyroid Hormone Deficiency
por: Tognini, Sara, et al.
Publicado: (2014)

The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease
por: Calsolaro, Valeria, et al.
Publicado: (2019)

Hypothyroidism in the Elderly: Who Should Be Treated and How?
por: Calsolaro, Valeria, et al.
Publicado: (2018)

Clarithromycin-induced rhabdomyolysis: a case report
por: Pasqualetti, Giuseppe, et al.
Publicado: (2012)

Thyroid Disrupting Chemicals
por: Calsolaro, Valeria, et al.
Publicado: (2017)

Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
por: Calsolaro, Valeria, et al.
Publicado: (2021)

Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
por: Calsolaro, Valeria, et al.
Publicado: (2019)

30-Day Potentially Preventable Hospital Readmissions In Older Patients: Clinical Phenotype And Health Care Related Risk Factors
por: Calsolaro, Valeria, et al.
Publicado: (2019)

Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient
por: Mantarro, Stefania, et al.
Publicado: (2012)

P2X(7) Receptor and APOE Polymorphisms and Survival from Heart Failure: A Prospective Study in Frail Patients in a Geriatric Unit
por: Pasqualetti, Giuseppe, et al.
Publicado: (2017)

Prognostic Value of Glycated Hemoglobin in Frail Older Diabetic Patients With Hip Fracture
por: Paterni, Simone, et al.
Publicado: (2021)

Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
por: Femminella, Grazia Daniela, et al.
Publicado: (2018)

Spontaneous muscle hematoma in older patients with COVID-19: two case reports and literature review
por: Rogani, Sara, et al.
Publicado: (2020)

Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope
por: Pasqualetti, Giuseppe, et al.
Publicado: (2017)

Missing Data Analysis in Drug-Naïve Alzheimer's Disease with Behavioral and Psychological Symptoms
por: Kwak, Yong Tae, et al.
Publicado: (2013)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
por: Brown, Joshua D.
Publicado: (2020)

Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer’s Disease Drug Development
por: Bachman, Shelby L., et al.
Publicado: (2023)

Different glomerular filtration rate estimating formula for prescribing DOACs in oldest patients: appropriate dosage and bleeding risk. Post hoc analysis of a prospective cohort
por: Calsolaro, Valeria, et al.
Publicado: (2021)

Interplay between Metabolism, Nutrition and Epigenetics in Shaping Brain DNA Methylation, Neural Function and Behavior
por: Pizzorusso, Tommaso, et al.
Publicado: (2020)

Magnitude of Drug–Drug Interactions in Special Populations
por: Bettonte, Sara, et al.
Publicado: (2022)

Medicinal Cannabis—Potential Drug Interactions
por: Alsherbiny, Muhammad A., et al.
Publicado: (2018)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in children
por: Francesca, Mori, et al.
Publicado: (2019)

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)

Drug–Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications
por: Di Mizio, Giulio, et al.
Publicado: (2021)

Behavioral and Psychological Symptoms in Alzheimer's Disease
por: Li, Xiao-Ling, et al.
Publicado: (2014)

Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain
por: Vázquez, Marta, et al.
Publicado: (2020)

Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer's Disease
por: Hwang, Inha, et al.
Publicado: (2017)

Mitochondria, Cognitive Impairment, and Alzheimer's Disease
por: Mancuso, M., et al.
Publicado: (2009)

Assessment of the drug–drug interaction potential for therapeutic proteins with pro‐inflammatory activities
por: Yu, Yanke, et al.
Publicado: (2023)

Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications
por: Spanakis, Marios, et al.
Publicado: (2023)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana, Justina P, et al.
Publicado: (2018)

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
por: Olloquequi, Jordi, et al.
Publicado: (2023)

Usefulness of lung ultrasound for selecting asymptomatic older patients with COVID 19 pneumonia
por: Okoye, Chukwuma, et al.
Publicado: (2021)

Mitochondrial Drugs for Alzheimer Disease
por: Bonda, David J., et al.
Publicado: (2009)

A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol versus Calcifediol in Older Patients with Hypovitaminosis D
por: Okoye, Chukwuma, et al.
Publicado: (2022)

Drug-drug interactions with raltegravir
por: Burger, David M
Publicado: (2009)

PS121. Evaluation of extrapyramidal side effects in the treatment of behavioral and psychological symptoms of dementia (BPSD): Interactions between anti-Alzheimer drugs and antidepressants
por: Shimizu, Saki, et al.
Publicado: (2016)

Pitfalls of Early Systemic Corticosteroids Home Therapy in Older Patients with COVID-19 Pneumonia
por: Okoye, Chukwuma, et al.
Publicado: (2022)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions
por: Hahn, Martina, et al.
Publicado: (2021)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v4uuori9fm249j8j386ojg9uav